Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06178315 · ClinicalTrials.gov registry record · NA

EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis

A NA study of Chronic Pancreatitis, sponsored by Orlando Health.

Recruiting
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT06178315 is a NA study of Chronic Pancreatitis that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 94 participants, below the 687-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06178315, a NA study of Chronic Pancreatitis, is actively recruiting participants, sponsored by Orlando Health.

RECRUITING
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

The aim of this randomized trial is to assess the efficacy of EUS-CPB in the alleviation of abdominal pain in patients with chronic pancreatitis.

Conditions Studied

Interventions

  • PROCEDURE Sham procedure
  • PROCEDURE EUS-guided celiac plexus block

Study Locations (1)

Florida

  • Orlando Health - Orlando

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2023-12-07
Est. Completion 2026-12-31
Phase NA

Sponsor

Orlando Health

21 total trials

What the Registry Record Tells You About NCT06178315

The ClinicalTrials.gov registry entry for NCT06178315 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 687-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (86% lower). The listed sponsor is Orlando Health, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Sham procedure is the first listed.

NCT06178315 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06178315 about?

NCT06178315 is a clinical study titled "EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis". The aim of this randomized trial is to assess the efficacy of EUS-CPB in the alleviation of abdominal pain in patients with chronic pancreatitis.

What is the current status of trial NCT06178315?

This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2023-12-07. Estimated completion is 2026-12-31.

What conditions does trial NCT06178315 study?

This clinical trial studies the following conditions: Chronic Pancreatitis.

What interventions are being tested in trial NCT06178315?

The interventions under investigation include: Sham procedure (PROCEDURE), EUS-guided celiac plexus block (PROCEDURE).

Who is sponsoring clinical trial NCT06178315?

This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06178315 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.